Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series-Reference-Cited by-同舟云学术

Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series

Published:2019-04-25 Issue: Volume: Page:e12931
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Ruiz‐Villaverde Ricardo¹^ORCID,Dominguez‐Cruz Javier²,Armario‐Hita Jose Carlos³,Martinez‐Pilar Leandro⁴,Alcantara‐Luna Sara⁵,Pereyra‐Rodriguez Jose Juan²

Affiliation:

1. Dermatology UnitHospital Universitario San Cecilio Granada Spain

2. Dermatology UnitHospital Universitario Virgen del Rocio Sevilla Spain

3. Dermatology UnitHospital Universitario Puerto Real Cádiz Spain

4. Dermatology UnitHospital Regional Universitario Carlos Haya Málaga Spain

5. Dermatology UnitHospital Juan Ramón Jiménez Huelva Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12931

Reference13 articles.

1. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis;Guttman‐Yassky E.;The Journal of Allergy and Clinical Immunology.,2018

2. Atopic dermatitis in adults: A diagnostic challenge;Silvestre Salvador J. F.;Journal of Investigational Allergology & Clinical Immunology,2017

3. Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders;Silverberg J. I.;Clinics in Dermatology,2017

4. Expert perspectives on management of moderate‐to‐severe atopic dermatitis: A multidisciplinary consensus addressing current and emerging therapies;Boguniewicz M.;The Journal of Allergy and Clinical Immunology. In Practice,2017

5. Changing perspectives in atopic dermatitis;Serra‐Baldrich E.;Allergologia et Immunopathologia,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience;Actas Dermo-Sifiliográficas;2024-02

2. [Artículo traducido]Eficacia y seguridad de dupilumab para el tratamiento de la dermatitis atópica grave en la práctica clínica: experiencia en un centro terciario;Actas Dermo-Sifiliográficas;2024-02

3. Considerations for managing elderly patients with atopic dermatitis;Expert Review of Clinical Immunology;2024-01-09

4. Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis;Australasian Journal of Dermatology;2023-12-06

5. Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience;World Allergy Organization Journal;2023-04